Megan O

Megan O'Banion

Director of Clinical Training
  • Director of Clinical Training
    Clinical Psychology
  • The Chicago School Los Angeles
Clinical Psychology
The Chicago School of Professional Psychology
617 W. 7th St. Los Angeles, CA 90017
617 W. 7th St.
Office Location
617 W. 7th St.
Office Phone
On-campus Ext.
Dr. Megan O’Banion has worked across a variety of settings (school-based, community health, day-treatment, partial hospitalization, and inpatient) and served a wide age spectrum of clients struggling with mental health concerns. She has worked extensively with research programs through UCSF Langley Porter Institute’s Department of Psychiatry (PART) and the San Francisco VA (CRIS) to expand and implement a nationally affiliated research program examining neuropsychological remediation and targeted CBT treatment for schizophrenia in ultra-high risk youth, as well as chronic patients. Dr. O’Banion completed an APA-accredited Pre-doctoral Internship and APPIC-accredited Post-Doctoral Fellowship at Sharp Healthcare where she honed her expertise in assessment, treatment, management, and program development/evaluation within an acute-care setting. Post licensure, Dr. O’Banion became Director of two Intensive Day Treatment programs (Elementary and Middle School) serving County Mental Health (AB2726/3632) clients identified as Severely Emotionally Disturbed. Her role was to redesign each treatment program to integrate education with intensive individualized and family/community-based interventions using wraparound philosophy and evidenced-based clinical models. Furthermore, she specializes in clinical supervision, staff development, program evaluation, and consultation/liaison services across communities. Dr. O’Banion continues to consult with Residential and Day Treatment programs for youth in both Northern and Southern California regarding crisis/risk management, psychodiagnostic assessment, specialized program development, supervision issues, and targeted treatment planning for SMI youth populations. Furthermore, she continues to present on topics related to utilization of neurospcyhological assessment result in SMI treatment planning, best practices in working with psychosis in youth, fostering continuity of care within today’s changing service models, and adapting evidenced-based treatment programs for higher acuity settings. In July 2011, Dr. O’Banion joined TCSPP as the new Director of Clinical Training for the Psy.D. Clinical Psychology Program and is thrilled to be a part of the institution.
  • B.A, Psychology and Social Behavior, University of California, Irvine
  • M.A., Clinical Psychology, The Wright Institute, Berkeley
  • Psy.D., Clinical Psychology, The Wright Institute, Berkeley
Licensed Psychologist, PSY 23744, California
Areas Of Expertise

Community Education

  • Traumatic Stress in Children: Using the Trauma Assessment Pathway Model
  • Disrupted Attachment and Treatment within Milieu Therapy
  • Psychosis in Youth: Triage to Treatment
  • Thinking Outside the Box: Community-Based Family Therapy
  • HIPPA and Privacy Practices: Children and Families
  • Evidence-Based Practice for Conduct Disorders
  • Self-Injurious Behaviors: Meaning and Interventions
  • Working with Anxiety: Elementary Aged Children and Families
  • Obsessive-Compulsive Disorder: Treatment in an Inpatient Setting (Youth and Adult)
  • Psychotic Disorders: Using Neuropsychological Assessment to Inform Treatment
  • Relationship Distress in Older Adults; Sex, Gender, and Identity: Diversity Seminar

Select Presentations/Publications 

  • O’Banion, M.G. (2009). Memory functions in youth with prodromal schizophrenia. Unpublished doctoral dissertation, The Wright Institute, Berkeley, CA.
  • O’Banion, M.G., Fisher, M., Loewy, R., & Vinogradov, S. (October 2008). Working memory as a candidate endophenotype in youth at ultra-high risk for schizophrenia Symposium presentation at the 28th annual meeting of the National Academy of Neuropsychology, New York, NY.
  • Whalen, C.K; Jamner, L.D; Henker, B; King, P.S; Zakroff, J; O’Banion, M. (April 2002). Is there a link between pharmacotherapy for Attention-Deficit/Hyperactivity Disorder (ADHD) and adolescent smoking? Poster session presented at the annual meeting of the Society of Behavioral Medicine, Washington, DC.
  • Moldazsky, E; Jamner, L.D; Gehricke, J.G; Zakroff, J; Whalen, C.K; Jamias, E; O’Banion, M. (March 2001). The Effects of Depressive Coping on Self-Reports of Illness in Adolescents. Presented at the Society of Behavioral Medicine in Seattle, WA.
  • O’Banion, M; Dierck, D; Whalen, C.K; Jamner, L.D; Gehricke, J.G. (March 2001). Smoking, gender, and adolescent adherence to research protocols. Symposium presentation at the annual meeting of the Society of Behavioral Medicine in Seattle, WA.
  • Whalen, C.K; O’Banion, M; Dierck, D; Jamner, L.D. (April 2000). Illness symptoms, perceived health, and adolescent smoking: Evidence of a dose-response relationship. Poster session presented at the annual meeting of the Society of Behavioral Medicine in Nashville, TN.

Professional Affiliations

  • American Psychological Association: Division 53(Society of Child & Adolescent Clinical Psychology); Division 40 (Clinical Neuropsychology)
  • California Psychological Association: Division I (Clinical and Professional Practice), Division II (Education and Training), and Division VIII (Neuropsychology)
  • National Academy of Neuropsychology
  • Society of Behavioral Medicine